| Baseline | Follow-up | ||
---|---|---|---|---|
 | Patients | Proxy respondents | Patients | Proxy respondents |
Total | 59 | 59 | 56 | 56 |
   Female (n) | 41 | 19 | 40 | 17 |
Age (years)* | 47.8 (8.9) | 49.2 (9.0) | 50.6 (9.1) | 52.4 (9.9) |
Years since MS onset* | 12.8 (7.2) | - | 14.8 (7.4) | - |
Type of MS (n) | Â | Â | Â | Â |
   Relapsing-remitting | 28 | - | 26 | - |
   Secondary progressive | 19 | - | 18 | - |
   Primary progressive | 10 | - | 10 | - |
   Other | 2 | - | 2 | - |
MSIS-29 | Â | Â | Â | Â |
   Physical scale* | 42.0 (24.1) | 42.8 (25.8) | 45.1 (25.3) | 50.0 (25.8) |
   Psychological scale* | 29.0 (22.6) | 33.3 (22.5) | 30.1 (23.5) | 39.0 (24.4) |
EDSS (median) | 4.5 | _ | 5.5 | _ |
HADS (n, depression/anxiety) | Â | Â | Â | Â |
   ≤ 7 | 42/37 | _ | _ | _ |
   8–10 | 7/10 | _ | _ | _ |
   ≥ 11 | 10/12 | _ | _ | _ |
BRB-N (n) | Â | Â | Â | Â |
   0 abnormal scores | 46 | _ | _ | _ |
   1–2 abnormal scores | 6 | _ | _ | _ |
   ≥3 abnormal scores | 5 | _ | _ | _ |
   Missing | 2 | _ | _ | _ |